Publications by the researcher in collaboration with Luis Miguel Antón Aparicio (24)

2024

  1. Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma

    Molecular Oncology, Vol. 18, Núm. 5, pp. 1143-1173

  2. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis

    Molecular Oncology, Vol. 18, Núm. 5, pp. 1093-1122

2021

  1. Signaling pathways in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 519-528

2015

  1. Radium-223 dichloride: A new paradigm in the treatment of prostate cancer

    Expert Review of Anticancer Therapy, Vol. 15, Núm. 3, pp. 339-348

  2. Vías de señalización en cáncer de colon

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 439-452

2013

  1. Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433

  2. Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)

    Clinical and Translational Oncology

2012

  1. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer

    International Journal of Molecular Sciences, Vol. 13, Núm. 4, pp. 4367-4387

  2. Squamous cell carcinoma ontogeny: Part I

    Squamous Cell Carcinoma (Nova Science Publishers, Inc.), pp. 1-36

  3. Squamous cell carcinoma ontogeny: Part II

    Squamous Cell Carcinoma (Nova Science Publishers, Inc.), pp. 37-68

2011

  1. Molecular basis of hypertension side effects induced by sunitinib

    Anti-Cancer Drugs, Vol. 22, Núm. 1, pp. 1-8

  2. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer

    International Journal of Oncology, Vol. 39, Núm. 5, pp. 1253-1264

2010

  1. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias

    Experimental and Molecular Pathology, Vol. 89, Núm. 2, pp. 197-203

  2. Evaluation of Plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients

    Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 6, pp. 1432-1440

2009

  1. Comprehensive lung injury pathology induced by mTOR inhibitors

    Clinical and Translational Oncology, Vol. 11, Núm. 8, pp. 499-510

  2. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: A pilot study

    Journal of Cancer Research and Clinical Oncology, Vol. 135, Núm. 9, pp. 1185-1195

  3. Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas

    Virchows Archiv, Vol. 455, Núm. 1, pp. 67-75

  4. MicroRNAs as circulating tumor cells biomarkers in gastrointestinal cancer

    EJC SUPPLEMENTS

2008

  1. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer

    Cancer Detection and Prevention, Vol. 32, Núm. 3, pp. 236-250

  2. Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS